Intra-Cellular Therapies, Inc

Bayer HealthCare Pharmaceuticals is the U.S.-based pharmaceuticals operation of Bayer HealthCare, an affiliate of Bayer. Bayer HealthCare Pharmaceuticals works for the development, manufacturing and marketing of drugs and treatment products to improve the human health. It operates through various business units, including women's health care, diagnostic imaging, general medicine, oncology, and hematology and neurology. It focuses on diagnosing, preventing and treating a variety of diseases and health conditions. Some the company s products include Cipro, Ciproxin, Avelox, Magnevist, Eovist, Ultravist, VistaTrak and Feridex I.V. It conducts research studies that focus on the development of treatment options and therapies for solid tumors and hematological malignancies.

Optinose is a specialty pharmaceutical company based in Yardley, PA, dedicated to improving the quality of life for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists. With a focus on innovation, Optinose aims to become the leading specialty pharmaceutical company in this field by creating and bringing to market innovative products that become the standard of care for ENT and allergy diseases. Optinose's first product utilizes their patented Bi-Directional Exhalation Delivery Systems (EDS) to deliver a potent steroid deep into the nose, targeting inflammation that is difficult to reach. In addition to their focus on ENT and allergy diseases, Optinose has also successfully developed and out-licensed a product for neurological and psychiatric disorders, and plans to partner with organizations specializing in central nervous system treatments for further development.Generated from the website

Fermata Pharma Inc. is a privately held company based in New York, NY, dedicated to developing innovative treatments for a range of diseases including Alzheimer's disease, lung cancer, an orphan disease, lymphangio-leiomyomatosis, and COVID-19. The company's research efforts also extend to exploring the potential benefits of shingles vaccination in reducing the risk of Alzheimer's and Parkinson's Disease, as presented at the National Vaccine Advisory Committee Meeting in Washington, D.C. on September 22, 2022.Generated from the website